ABERRANT IMMUNE LANDSCAPE IN BONE MARROW OF HIGH-RISK MYELODYSPLASTIC SYNDROME PATIENTS

被引：0
|
作者：
Rai, R. [1 ]
Patel, F. [1 ]
Feld, J. [1 ]
Melana, S. [1 ]
Demakos, E. [1 ]
Horowitz, A. [2 ]
Silverman, L. [1 ]
机构：
[1] Tisch Canc Inst, Icahn Sch Med, Hematol Med Oncol, New York, NY USA
[2] Icahn Sch Med, Lipshultz Precis Immunol Inst, Tisch Canc Inst, Dept Oncol Sci, New York, NY USA
来源：
LEUKEMIA RESEARCH | 2023年 / 128卷
关键词：
D O I：
10.1016/j.leukres.2023.107215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P080
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Complete Remission of High-Risk Myelodysplastic Syndrome With Combination Therapy
    Singh, Ashmin
    Sanghavi, Nairuti
    Popat, Dhara
    Bandari, Vandana
    Alfaraj, Abeer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S385 - S386
  • [32] High expression of APAF-1XL in bone marrow cells of low risk myelodysplastic syndrome
    Benites, B. D.
    Traina, F.
    Duarte, A. S. S.
    Costa, F. F.
    Saad, S. T. O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 392 - 392
  • [33] CORONARY ARTERY BYPASS GRAFTING IN HIGH-RISK MYELODYSPLASTIC SYNDROME
    Zhang, Kathleen
    Wiesehan, Holly
    Westervelt, Peter
    Maniar, Hersh
    Krone, Ronald
    Lenihan, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2688 - 2688
  • [34] Novel therapies in low- and high-risk myelodysplastic syndrome
    Germing, Ulrich
    Schroeder, Thomas
    Kaivers, Jennifer
    Kuendgen, Andrea
    Kobbe, Guido
    Gattermann, Norbert
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (10) : 893 - 908
  • [35] Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
    Nishihori, Taiga
    Perkins, Janelle
    Mishra, Asmita
    Komrokji, Rami
    Kim, Jongphil
    Kharfan-Dabaja, Mohamed A.
    Perez, Lia
    Lancet, Jeffrey
    Fernandez, Hugo
    List, Alan
    Anasetti, Claudio
    Field, Teresa
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (06) : 776 - 780
  • [36] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR 93 PATIENTS WITH MYELODYSPLASTIC SYNDROME
    ANDERSON, JE
    APPELBAUM, FR
    FISHER, LD
    SCHOCH, G
    SHULMAN, H
    ANASETTI, C
    BENSINGER, WI
    BRYANT, E
    BUCKNER, CD
    DONEY, K
    MARTIN, PJ
    SANDERS, JE
    SULLIVAN, KM
    THOMAS, ED
    WITHERSPOON, RP
    HANSEN, JA
    STORB, R
    BLOOD, 1993, 82 (02) : 677 - 681
  • [37] Appropriate Timing of Allogeneic Bone Marrow Transplant in Patients with Myelodysplastic Syndrome
    Alnimer, Yanal
    Munker, Reinhold
    Qasrawi, Ayman
    Monohan, Gregory
    Iragavarapu, Chait
    Yalniz, Fevzi
    BLOOD, 2024, 144 : 4605 - 4606
  • [38] Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients
    Nyåkern, M
    Tazzari, PL
    Finelli, C
    Bosi, C
    Follo, MY
    Grafone, T
    Piccaluga, PP
    Martinelli, G
    Cocco, L
    Martelli, AM
    LEUKEMIA, 2006, 20 (02) : 230 - 238
  • [39] Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients
    M Nyåkern
    P L Tazzari
    C Finelli
    C Bosi
    M Y Follo
    T Grafone
    P P Piccaluga
    G Martinelli
    L Cocco
    A M Martelli
    Leukemia, 2006, 20 : 230 - 238
  • [40] MYELODYSPLASTIC SYNDROME WITH EOSINOPHILIA IN BONE-MARROW
    MATSUSHIMA, T
    MURAKAMI, H
    SAWAMURA, M
    TAMURA, J
    SAKURA, T
    MATSUMOTO, M
    HIRABAYASHI, H
    MIYAWAKI, S
    SIMANO, S
    SATO, S
    TSUCHIYA, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (04) : 636 - 638
12345